Krishna Institute of Medical Sciences (KIMS) — share transfer

📢 Key Event
KIMS receives SEBI-mandated share transfer agent certificate for Q1 FY27

💡 Investor Takeaway
This confirms regulatory compliance and proper handling of share dematerialization for the quarter.

KIMS announced receipt of a SEBI-mandated share transfer agent certificate for the June 2026 quarter, confirming dematerialization of securities and their listing status. The filing validates compliance with depositary regulations and updates shareholder records.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KIMS ✨ Ask AI About This

About Krishna Institute of Medical Sciences Limited (KIMS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹30,476.58 Cr P/E: 80.3

View full KIMS stock details →

📡 Get AI alerts when KIMS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KIMS — Free

💡 Ask AI about this filing

"What was the total dematerialized share volume in Q1 FY27?" "How does this compare to previous quarter's dematerialization activity?" "What is the current status of shareholder accounts after dematerialization?"

Ask AI Free →

📊 More KIMS filings

See all KIMS filings →

🔥 Also filed on 17 July 2026

WIPRO Wipro Limited Financial Results TATAELXSI Tata Elxsi Limited Financial Results TATATECH Tata Technologies Limited Financial Results JAYNECOIND Jayaswal Neco Industries Limited Financial Results FEDERALBNK The Federal Bank Limited Corporate Action UYFINCORP U. Y. Fincorp Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KIMS files new disclosures

Track KIMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.